Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in CGON — CG Oncology, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in CGON

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,112,145
-$634,202 QoQ
Shares Held
15,653
-39.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#118
of 226 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGON Over Time

Shares Held

Position Value (USD)

Derivatives in CGON

reported options exposure · as of Jun 30, 2026
CallValue
$46,196,710
CallShares
650,200
PutValue
$11,559,835
PutShares
162,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,650,012,247 across 349 Biotechnology names. CGON ranks #118 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CGON

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,112,145 15,653
2026-06-30 $46,196,710 650,200
2026-06-30 $11,559,835 162,700
2026-03-31 $2,043,936 30,200
2026-03-31 $1,746,347 25,803
2026-03-31 $25,495,056 376,700
2025-12-31 $10,081,056 242,800
2025-09-30 $2,034,140 50,500
2025-09-30 $362,520 9,000
2025-06-30 $4,180,800 160,800
2025-06-30 $1,339,000 51,500
2025-06-30 $2,438,618 93,793
2025-03-31 $742,047 30,300
2025-03-31 $2,007,812 81,985
2024-12-31 $1,080,346 37,669
2024-12-31 $4,686,312 163,400
2024-09-30 $1,143,219 30,300
2024-09-30 $2,003,463 53,100
2024-09-30 $490,225 12,993
2024-06-30 $202,048 6,400
2024-03-31 $489,441 11,149